☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
RNAi Therapeutics
Top 20 RNAi Therapeutic Companies of 2024
July 22, 2024
Alnylam Signs a License Agreement with PeptiDream to Develop and Commercialize Peptide-siRNA Conjugates for Delivery of RNAi Thera...
July 30, 2021
Regeneron Collaborates with Alnylam to Discover- Develop and Commercialize RNAi Therapeutics for Ophthalmic and CNS Disorders
April 9, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.